Fostamatinib
C-935788-061
Phase 3 small_molecule completed
Quick answer
Fostamatinib for Covid19 is a Phase 3 program (small_molecule) at RIGEL PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- RIGEL PHARMACEUTICALS INC
- Indication
- Covid19
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed